Goserelin

Goserelin is a synthetic analogue of luteinizing hormone-releasing hormone (LHRH) used to treat hormone-sensitive cancers including prostate and breast cancer, as well as certain benign gynecological disorders. It is grouped under the following drug class(es): Antineoplastic agents, Hormones, LHRH analogues and Peptides. The directory classifies it as a commercial API with a peptide source/manufacturing origin. Other names for this substance include Gosereline and Goserelina. Its PubChem CID is 5311128.

CAS No 65807-02-05
Molecular Formula C59H84N18O14
Molecular Weight 1269.4 g/mol
Synonyms (2S)-N-[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2R)-1-[[(2S)-1-[[(2S)-1-[(2S)-2-[(carbamoylamino)carbamoyl]pyrrolidin-1-yl]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-3-[(2-methylpropan-2-yl)oxy]-1-oxopropan-2-yl]amino]-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]amino]-3-hydroxy-1-oxopropan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-3-(1H-imidazol-5-yl)-1-oxopropan-2-yl]-5-oxopyrrolidine-2-carboxamide

Frequently Asked Questions